The store will not work correctly when cookies are disabled.
2-acetamido-3-((5-(hydroxymethyl)-3,6-dimethylpyrazin-2-yl)methylthio)propanoic acid
ID: ALA3752212
PubChem CID: 102340571
Max Phase: Preclinical
Molecular Formula: C13H19N3O4S
Molecular Weight: 313.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)NC(CSCc1nc(C)c(CO)nc1C)C(=O)O
Standard InChI: InChI=1S/C13H19N3O4S/c1-7-10(4-17)14-8(2)11(15-7)5-21-6-12(13(19)20)16-9(3)18/h12,17H,4-6H2,1-3H3,(H,16,18)(H,19,20)
Standard InChI Key: UAVANFFLSCJVSC-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 21 0 0 0 0 0 0 0 0999 V2000
2.5917 -6.0086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8912 -5.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5913 -7.2086 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5524 -5.4086 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 -3.0039 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3383 -1.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3383 1.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5973 1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5956 2.7031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1894 -6.0109 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1873 -7.5117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1470 -8.1099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2253 -8.1139 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 2 0
1 5 1 0
8 9 1 0
8 10 2 0
9 11 2 0
11 12 1 0
12 13 2 0
10 13 1 0
13 14 1 0
9 15 1 0
16 17 1 0
12 16 1 0
7 8 1 0
6 7 1 0
3 6 1 0
2 18 1 0
18 19 1 0
19 20 1 0
19 21 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 313.38 | Molecular Weight (Monoisotopic): 313.1096 | AlogP: 0.41 | #Rotatable Bonds: 7 |
Polar Surface Area: 112.41 | Molecular Species: ACID | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.33 | CX Basic pKa: 0.79 | CX LogP: -1.69 | CX LogD: -5.11 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.67 | Np Likeness Score: -0.32 |
References
1. Zhu HH, Chen YQ, Cheng D, Li W, Wang TL, Wen HM, Chen L, Liu J.. (2016) Synthesis and positive inotropic activity evaluation of liguzinediol metabolites., 26 (3): [PMID:26725025] [10.1016/j.bmcl.2015.12.072] |
2. Zhu HH, Chen YQ, Cheng D, Li W, Wang TL, Wen HM, Chen L, Liu J.. (2016) Synthesis and positive inotropic activity evaluation of liguzinediol metabolites., 26 (3): [PMID:26725025] [10.1016/j.bmcl.2015.12.072] |